Actionable insights straight to your inbox

Equities logo

Fate Therapeutics Collaborating on New Cancer Treatment

The partnership between the research team at the University of Minnesota and Fate Therapeutics is looking at a new course of cancer treatment, which focuses on the use of natural killer (NK) cells.
Fate Therapeutics ($FATE) is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including